Doctors Law Firms Regulations 
KHN
APRIL 16, 2024
” said Sanket Dhruva , a cardiologist and an expert in medical device safety and regulation at the University of California-San Francisco. A review of the FDA device database shows at least 130 reports related to HeartMate II or 3 that mention the complication reported by regulators. “Why doesn’t the public know?”
KHN
DECEMBER 19, 2023
Hospitals, doctors, and others report device-related deaths, serious injuries, and malfunctions to manufacturers, who are required to investigate and report cases to the FDA. ” Even doctors cannot use the FDA database as a tool to effectively counsel patients, Dhruva added. ” he said.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Home Health Care
DECEMBER 20, 2022
However, providers need to be sure they’re not running afoul of the federal laws, or the state law equivalents, that regulate the financial relationships between agencies and their referral sources. Strong referrals can be the lifeblood of a thriving home-based care business.
Home Health Care
DECEMBER 1, 2022
Matt Wolfe, a health care attorney with the law firm Baker Donaldson, believes that value-based care, staffing struggles and the emergence of telehealth will all present even more struggles for providers in 2023. CON laws don’t exist in all states, and even in those states that do have CON laws, not all include home health.
Home Health Care
APRIL 25, 2024
“In our industry, you see non-solicitation agreements, which are designed to protect the business of the provider, but not to restrict the caregiver,” Angelo Spinola, the home health, home care and hospice chair at the law firm Polsinelli, previously told Home Health Care News. doctors are subject to non-competes.
Bill Of Health
OCTOBER 28, 2024
The Petrie-Flom Center is excited to announce our affiliated researchers for the Project on Psychedelics Law and Regulation (POPLAR) and our new project , Psychedelic Use, Law, and Spiritual Experience (PULSE). is one of the nation’s leading authorities on federalism, separation and powers, and drug law and policy.
Expert insights. Personalized for you.
101 
Let's personalize your content